propoven
fresenius kabi deutschland gmbh - propofolis - injekcinė ar infuzinė emulsija užpildytame švirkšte - 20 mg/ml; 10 mg/ml - propofol
metronidazole vioser
vioser s.a. parenteral solutions industry - metronidazolas - infuzinis tirpalas - 500 mg/100 ml - metronidazole
norepinephrine kalceks
as kalceks - norepinefrino tartratas - koncentratas infuziniam tirpalui - 1 mg/ml - norepinephrine
norepinephrine kabi
fresenius kabi polska sp.z.o.o. - noradrenalinas - koncentratas infuziniam tirpalui - 1 mg/ml - norepinephrine
abecma
bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antinavikiniai vaistai - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
ondansetron accord
accord healthcare b.v. - ondansetronas - injekcinis ar infuzinis tirpalas - 2 mg/ml - ondansetron
anesia
baxter holding b.v. - propofolis - injekcinė ar infuzinė emulsija - 10 mg/ml; 20 mg/ml - propofol
esomeprazole accord
accord healthcare b.v. - ezomeprazolas - milteliai injekciniam ar infuziniam tirpalui - 40 mg - esomeprazole
tranexamic acid baxter
baxter holding b.v. - traneksamo rūgštis - injekcinis ar infuzinis tirpalas - 100 mg/ml - tranexamic acid
ofost
as grindeks - oksitocinas - injekcinis ar infuzinis tirpalas - 5 tv/ml - oxytocin